NCJ Number
253029
Date Published
November 2018
Length
8 pages
Annotation
Information and data are presented for Puerto Rico's Prescription Drug Monitoring Program (PDMP), which is administered by Puerto Rico's Mental Health and Anti-Addiction Services Administration.
Abstract
The PDMP's email address is provided, along with website addresses for the home page, enrollment, queries, and data upload. Contact information is provided for the PDMP's Program Manager and Program Coordinator. Data for 2017 cover the state population (3,337,177), DEA registered prescribers (10,669), and DEA registered dispensers (1,110). PDMP available reports are listed. Significant dates for the PDMP pertain to enabling legislation (July 2017), becoming operational (June 2018), initial user access (June 2018), on-line access (June 2018), and electronic reporting (May 2018). Source information is provided for statutes and rules related to the policies and procedures of the PDMP. Reporting frequency for monitored drugs is 15 days. Drugs monitored are controlled substances on schedules II, III, IV, and V. Other required reporting pertains to marijuana data. Miscellaneous capabilities and policies of the PDMP are listed. There is no indication that prescribers and dispensers of monitored drugs are required to enroll with or use the PDMP. Before law enforcement agencies are allowed to query PDMP data, there must be a subpoena, court order/approval, and search warrant. The nature of the query must be submitted in writing. All data and information are purged from the PDMP after 4 years. Training in the use of the PDMP is available for various professional groups, but training is not a requirement for using the PDMP. A listing of PDMP technological capabilities encompasses ASAP versions accepted; data transmission methods allowed; required data transmitters (pharmacy in-state and veterinarians); data collection, storage, generation, and access; interstate data sharing; data integration; and patient matching.